Drugs of Abuse (DOA) Testing Global Market Report 2024

Description

Drug of abuse (DOA) testing involves examining substances, such as drugs, chemicals, or plant products, typically used recreationally. This includes marijuana, cocaine, opioids, amphetamines, alcohol, and PCP, which are screened for on a drug panel. Clinical screening methods use the patient's urine, saliva, blood, hair, or sweat for this purpose.

Drug of Abuse (DOA) testing encompasses various products and services, including analyzers, rapid testing devices, consumables, and laboratory services. Analyzers, automatic devices measuring chemical concentrations, play a crucial role in this domain. The testing involves sample types such as urine, hair, oral fluid, and breath, with applications in pain management, criminal justice, and workplace screening. End-users of DOA testing include hospitals, diagnostic laboratories, forensic laboratories, and other relevant entities.

The drugs of abuse (DOA) testing market research report is one of a series of new reports from. The Business Research Company that provides drugs of abuse (DOA) testing market statistics, including drugs of abuse (DOA) testing industry global market size, regional shares, competitors with a drugs of abuse (DOA) testing market share, detailed drugs of abuse (DOA) testing market segments, market trends and opportunities, and any further data you may need to thrive in the drugs of abuse (DOA) testing industry. This drug of abuse (DOA) testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The drugs of abuse (doa) testing market size has grown strongly in recent years. It will grow from $6.6 billion in 2023 to $7.25 billion in 2024 at a compound annual growth rate (CAGR) of 9.8%. The growth witnessed in the historical period can be ascribed to factors such as government regulations and workplace policies, pre-employment screening practices, law enforcement and legal procedures, drug rehabilitation programs, and compliance measures within the transportation industry.

The drugs of abuse (doa) testing market size is expected to see strong growth in the next few years. It will grow to $10.48 billion in 2028 at a compound annual growth rate (CAGR) of 9.6%. The projected growth in the upcoming forecast period can be linked to the expansion of sports and athletics testing, heightened awareness and education regarding drug testing, a surge in drug-related crimes, the adoption of corporate wellness programs, and advancements in testing methods. Key trends anticipated in this period encompass the utilization of portable and handheld testing devices, the implementation of Laboratory Information Management Systems (LIMS), a focus on synthetic drug testing, a growing demand for cannabis testing, and the integration of artificial intelligence (AI) for result interpretation.

The rising demand for drug abuse treatment is anticipated to drive the growth of the drugs of abuse (DOA) testing market. Drug abuse, or substance abuse, involves the harmful use of substances by individuals. Drug testing plays a crucial role in identifying compounds not typically present in the body. The testing process includes screening tests followed by confirmatory tests to detect and verify the presence of specific substances. The growing need for drug abuse treatment is expected to contribute to the market's expansion. For example, in June 2021, the United Nations Office on Drugs and Crime (UNODC) reported in the World Drug Report that over 36 million individuals worldwide have drug use disorders. This increasing demand for drug abuse treatment is a key driver for the growth of the drugs of abuse (DOA) testing market.

The growing demand for hospitals is anticipated to drive the expansion of the drugs of abuse (DOA) testing market. Hospitals, as comprehensive healthcare institutions, play a crucial role in delivering a broad spectrum of medical services, treatment, and care for individuals facing illness or injury. The integration of drugs of abuse (DOA) testing within hospitals facilitates early detection of substance abuse, enabling customized treatment plans, enhancing clinical decision-making, ensuring patient safety, and contributing to public health, workplace safety, and efficient healthcare resource utilization. As of August 2023, there are reported to be 1148 hospitals in the UK, emphasizing the significant role hospitals play in healthcare services. Hence, the increasing demand for hospitals is a key factor propelling the growth of the drugs of abuse (DOA) testing market.

Major players in the drugs of abuse (DOA) testing market are directing their efforts towards developing cutting-edge products, including software-as-a-service (SaaS) platforms, to reinforce their market presence. Software-as-a-Service (SaaS) represents a software distribution model where applications are hosted by a third-party provider and accessed by customers over the internet. A notable example is the introduction of the Addison drug discovery software by Merck KGaA, a US-based science and technology company, in December 2023. This software accelerates drug development and enhances the success rate of novel medications and therapies by integrating computer-aided drug design, machine learning, and generative AI. Addison provides recommendations on optimal methods for synthesizing medications, bridging the gap between virtual molecule design and practical manufacturability. By extracting hidden insights from extensive datasets, the platform increases the likelihood of patients benefiting from innovative treatments.

Key players in the drugs of abuse (DOA) testing market are actively introducing new products, including advanced drug testing, to stay ahead in the market competition. Drug testing involves analyzing biological specimens, such as urine, to identify specific drugs or their metabolites. In December 2022, Omega Laboratories Inc., a US-based company specializing in forensic toxicology and hair testing services, launched urine drugs of abuse testing services. These services are known for their ease of use, rapid effects, and affordability. The laboratory provides accredited urine drug testing services, ensuring high quality and precision in test results. Serving over 6,000 clients worldwide, the organization employs both screening and confirmatory testing in urine drug abuse testing services to ensure the accuracy and reliability of the results.

In February 2021, Thermo Fisher Scientific Inc., a US-based company specializing in scientific research services, entered into a partnership with Mindray Medical International Limited, a China-based medical technology company. The collaboration aims to provide clinical laboratories, hospitals, and the criminal justice system with reliable and cost-effective tools for drug misuse screening. This partnership allows Thermo Fisher Scientific to address the needs of testing facilities looking to enhance or expand their testing capabilities, as well as those seeking to integrate and centralize their testing processes.

Major companies operating in the drugs of abuse (doa) testing market report are Siemens AG, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Laboratory Corporation of America Holdings, Quest Diagnostics Inc., Zimmer Biomet Holdings Inc., bioMerieux Inc., Dragerwerk AG & Co. KGaA, Natera Inc., Aegis Sciences Corporation, NMS Labs, Clinical Reference Laboratory Inc., Cordant Health Solutions, Millennium Health, ACM Global Laboratories, Psychemedics Corporation, Alfa Scientific Designs Inc., Alere Toxicology Services, Omega Laboratories Inc., BioTek Laboratories, Premier Biotech Inc., Dominion Diagnostics LLC, Randox Toxicology Ltd., Cansford Laboratories Ltd., United States Drug Testing Laboratories Inc., Homology Medicines Inc., American Bio Medica Corporation, Confirm BioSciences, Immunalysis Corporation, Medtox Diagnostics Inc., Forensic Fluids Laboratories

North America was the largest region in the drugs of abuse (DOA) testing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the global drugs of abuse (DOA) testing market report during the forecast period. The regions covered in the drugs of abuse (doa) testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the drugs of abuse (doa) testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The drugs of abuse (DOA) testing market includes revenues earned by entities by providing services such as analyzers, rapid testing devices, consumables, and laboratory services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Drugs of Abuse (DOA) Testing Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on drugs of abuse (doa) testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for drugs of abuse (doa) testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The drugs of abuse (doa) testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

1) By Product And Service: Analyzers; Rapid Testing Devices; Consumables; Laboratory Services
2) By Sample Type: Urine; Hair; Oral Fluid; Breath
3) By Application: Pain Management; Criminal Justice; Workplace Screening
4) By End User: Hospitals; Diagnostic Laboratories; Forensic Laboratories; Other End Users
Companies Mentioned: Siemens AG; F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific Inc.; Abbott Laboratories; Danaher Corporation
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r15548

1. Executive Summary

2. Drugs of Abuse (DOA) Testing Market Characteristics

3. Drugs of Abuse (DOA) Testing Market Trends And Strategies

4. Drugs of Abuse (DOA) Testing Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market

5. Global Drugs of Abuse (DOA) Testing Market Size and Growth

5.1. Global Drugs of Abuse (DOA) Testing Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Drugs of Abuse (DOA) Testing Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Drugs of Abuse (DOA) Testing Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Drugs of Abuse (DOA) Testing Market Segmentation

6.1. Global Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Analyzers
Rapid Testing Devices
Consumables
Laboratory Services
6.2. Global Drugs of Abuse (DOA) Testing Market, Segmentation By Sample Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Urine
Hair
Oral Fluid
Breath
6.3. Global Drugs of Abuse (DOA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Pain Management
Criminal Justice
Workplace Screening
6.4. Global Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Hospitals
Diagnostic Laboratories
Forensic Laboratories
Other End Users

7. Drugs of Abuse (DOA) Testing Market Regional And Country Analysis

7.1. Global Drugs of Abuse (DOA) Testing Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Drugs of Abuse (DOA) Testing Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Drugs of Abuse (DOA) Testing Market

8.1. Asia-Pacific Drugs of Abuse (DOA) Testing Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Drugs of Abuse (DOA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Drugs of Abuse (DOA) Testing Market

9.1. China Drugs of Abuse (DOA) Testing Market Overview
9.2. China Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Drugs of Abuse (DOA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Drugs of Abuse (DOA) Testing Market

10.1. India Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Drugs of Abuse (DOA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Drugs of Abuse (DOA) Testing Market

11.1. Japan Drugs of Abuse (DOA) Testing Market Overview
11.2. Japan Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Drugs of Abuse (DOA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Drugs of Abuse (DOA) Testing Market

12.1. Australia Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Drugs of Abuse (DOA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Drugs of Abuse (DOA) Testing Market

13.1. Indonesia Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Drugs of Abuse (DOA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Drugs of Abuse (DOA) Testing Market

14.1. South Korea Drugs of Abuse (DOA) Testing Market Overview
14.2. South Korea Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Drugs of Abuse (DOA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Drugs of Abuse (DOA) Testing Market

15.1. Western Europe Drugs of Abuse (DOA) Testing Market Overview
15.2. Western Europe Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Drugs of Abuse (DOA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Drugs of Abuse (DOA) Testing Market

16.1. UK Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Drugs of Abuse (DOA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Drugs of Abuse (DOA) Testing Market

17.1. Germany Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Drugs of Abuse (DOA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Drugs of Abuse (DOA) Testing Market

18.1. France Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Drugs of Abuse (DOA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Drugs of Abuse (DOA) Testing Market

19.1. Italy Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Drugs of Abuse (DOA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Drugs of Abuse (DOA) Testing Market

20.1. Spain Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Drugs of Abuse (DOA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Drugs of Abuse (DOA) Testing Market

21.1. Eastern Europe Drugs of Abuse (DOA) Testing Market Overview
21.2. Eastern Europe Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Drugs of Abuse (DOA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Drugs of Abuse (DOA) Testing Market

22.1. Russia Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Drugs of Abuse (DOA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Drugs of Abuse (DOA) Testing Market

23.1. North America Drugs of Abuse (DOA) Testing Market Overview
23.2. North America Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Drugs of Abuse (DOA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Drugs of Abuse (DOA) Testing Market

24.1. USA Drugs of Abuse (DOA) Testing Market Overview
24.2. USA Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Drugs of Abuse (DOA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Drugs of Abuse (DOA) Testing Market

25.1. Canada Drugs of Abuse (DOA) Testing Market Overview
25.2. Canada Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Drugs of Abuse (DOA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Drugs of Abuse (DOA) Testing Market

26.1. South America Drugs of Abuse (DOA) Testing Market Overview
26.2. South America Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Drugs of Abuse (DOA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Drugs of Abuse (DOA) Testing Market

27.1. Brazil Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Drugs of Abuse (DOA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Drugs of Abuse (DOA) Testing Market

28.1. Middle East Drugs of Abuse (DOA) Testing Market Overview
28.2. Middle East Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Drugs of Abuse (DOA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Drugs of Abuse (DOA) Testing Market

29.1. Africa Drugs of Abuse (DOA) Testing Market Overview
29.2. Africa Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Drugs of Abuse (DOA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Drugs of Abuse (DOA) Testing Market Competitive Landscape And Company Profiles

30.1. Drugs of Abuse (DOA) Testing Market Competitive Landscape
30.2. Drugs of Abuse (DOA) Testing Market Company Profiles
- 30.2.1. Siemens AG
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. F. Hoffmann-La Roche Ltd.
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. Thermo Fisher Scientific Inc.
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. Abbott Laboratories
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. Danaher Corporation
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Drugs of Abuse (DOA) Testing Market Other Major And Innovative Companies

31.1. Laboratory Corporation of America Holdings
31.2. Quest Diagnostics Inc.
31.3. Zimmer Biomet Holdings Inc.
31.4. bioMerieux Inc.
31.5. Dragerwerk AG & Co. KGaA
31.6. Natera Inc.
31.7. Aegis Sciences Corporation
31.8. NMS Labs
31.9. Clinical Reference Laboratory Inc.
31.10. Cordant Health Solutions
31.11. Millennium Health
31.12. ACM Global Laboratories
31.13. Psychemedics Corporation
31.14. Alfa Scientific Designs Inc.
31.15. Alere Toxicology Services

32. Global Drugs of Abuse (DOA) Testing Market Competitive Benchmarking

33. Global Drugs of Abuse (DOA) Testing Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Drugs of Abuse (DOA) Testing Market

35. Drugs of Abuse (DOA) Testing Market Future Outlook and Potential Analysis

35.1 Drugs of Abuse (DOA) Testing Market In 2028 - Countries Offering Most New Opportunities
35.2 Drugs of Abuse (DOA) Testing Market In 2028 - Segments Offering Most New Opportunities
35.3 Drugs of Abuse (DOA) Testing Market In 2028 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer